John Reiners, Ph.D.
John Reiners, Ph.D.
Department of Pharmacology
Scott Hall, Rm 7334
540 E. Canfield, Detroit, MI 48201
Office Phone(313) 577-5594
Office Fax(313) 577-0082
Characterization the signaling pathways and mechanisms involved in the regulation of CYP1A1 gene following exposure to polycyclic aromatic hydrocarbons and polyhalogenated aromatics such as dioxins.
Although the term 'death' has negative connotations, it is a normal physiological process and necessary for maintenance of homeostasis. Indeed, cancer is often a consequence of defective cell death pathways. The Reiners laboratory is interested in understanding the processes of programmed cell death, and determining how different types of toxicants and insults to specific organelles (lysosomes, endoplasmic reticulum, nucleus, mitochondria) initiate programmed cell death pathways. Such information has significant therapeutic applications. A second related area of interest revolves around the study of the aryl hydrocarbon receptor (AhR). The AhR is a ubiquitously expressed, ligand-activated transcription factor. Its ligand-dependent activities influence processes involved in xenobiotic metabolism, immune function, development, cell cycle progression, and cell death. The Reiners laboratory is interested in: 1) the signaling processes that regulate AhR function; 2) AhR regulation of cholesterol trafficking and homeostasis; and the 3) ligand-independent functions of the AhR. In relation to the latter, particular attention is being focused on how the AhR r
PhD (1977; Biochemistry): Purdue University, West Lafayette, Indiana
BS (1971; Biochemistry): University of Minnesota, Minneapolis, Minnesota
Postdoctoral Fellow (1977 - 1980), Baylor College of Medicine, Department of Pharmacology, Houston, Texas
Research Associate (1980 - 1982), University of Tennessee Graduate School of Biomedical Sciences, Oak Ridge, Tennessee
Assistant Professor (Research, 1982-1983), University of Tennessee Graduate School of Biomedical Sciences, Oak Ridge, TN
Assistant Professor of Carcinogenesis (1983 - 1988), University of Texas M.D. Anderson Cancer Center, Science Park Research Division, Smithville, TX
Associate Professor of Carcinogenesis (1988 - 1992, tenured), University of Texas M.D. Ancerson Cancer Center, Science Park Research Division, Smithville, TX
Associate Professor (1992 - 1996, tenured), Institute of Chemical Toxicology & Department of Pharmacology, Wayne State University, Detroit, MI
Professor (1996 - present, tenured), Institute of Environmental Health Sciences & Department of Pharmacology, Wayne State University, Detroit, MI
- Kessel D, Reiners J Jr. Light-Activated Pharmaceuticals: Mechanisms and Detection. Isr J Chem. 2012;52:674-680.
- Kessel DH, Price M, Reiners JJ Jr. ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage. Autophagy. 2012;8:1333-41.
- Elliott A, Joiakim A, Mathieu PA, Duniec-Dmuchowski Z, Kocarek TA, Reiners JJ Jr. p-Anilinoaniline enhancement of dioxin-induced CYP1A1 transcription and aryl hydrocarbon receptor occupancy of CYP1A1 promoter: role of the cell cycle. Drug Metab Dispos. 2012;40:1032-40.
- Wojtkowiak JW, Sane KM, Kleinman M, Sloane BF, Reiners JJ Jr, Mattingly RR. Aborted autophagy and nonapoptotic death induced by farnesyl transferase inhibitor and lovastatin. J Pharmacol Exp Ther. 2011;337:65-74.